Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

New diagnosis of Barrett's esophagus changes insurance status

A diagnosis of Barrett's esophagus more than doubles life insurance premiums, and impacts the availability of health insurance, reports March's issue of The American Journal of Gastroenterology.

News image

fiogf49gjkf04

Barrett's esophagus is associated with an increased risk of adenocarcinoma of the esophagus.

Despite this increased risk, most cohort studies demonstrate that the mean life expectancy of subjects with Barrett's esophagus is no different than age-matched controls.

The indirect costs associated with a diagnosis of Barrett's esophagus are unclear.

Dr Shaheen and colleagues assessed the effect of a diagnosis of Barrett's esophagus on insurance premiums.

The researchers assessed 20 national life insurance companies (10 in southern California, 10 in North Carolina) to determine the effect of a diagnosis of Barrett's esophagus on life insurance premiums.

The investigators’ base case in Los Angeles was a 36 year old female nonsmoker, and in North Carolina, a 43 year old Caucasian male nonsmoker, both in excellent health except for a diagnosis of prevalent Barrett's esophagus with no dysplasia.

The investigative team then requested a policy of 20 year guaranteed term life insurance in the amount of $1,000,000.

Companies refused to provide health insurance to the individual with Barrett's esophagus or requested further medical review
The American Journal of Gastroenterology

Companies were asked for their best price exclusive of the Barrett's esophagus, and also their best price when considering Barrett's esophagus as a preexisting condition.

The researchers subsequently sent a physician's letter explaining Barrett's esophagus and providing data substantiating a normal life expectancy in the condition to those companies not offering the "preferred" rates.

The team also asked companies for health insurance quotes, including premiums and deductibles, inclusive and exclusive of the diagnosis of Barrett's esophagus.

The investigators contacted 29 national insurance companies and for the 43 year old man with no Barrett's esophagus, the yearly "preferred" premium for life insurance averaged $1,255.

The mean cost of the policies offered to the same individual with Barrett's esophagus as a preexisting condition was $2,731.

The researchers noted that for the 36 year old female the base rate exclusive of Barrett's esophagus was $517, with a range of $472 - $551.

After inclusion of the diagnosis of Barrett's esophagus, the mean rate rose by 177%, to $1,434, with a range of $1,144 - $1,896.

The investigators reported that companies either refused to provide health insurance to the individual with Barrett's esophagus or would not provide a quote without review of the medical record.

The team observed that none of the insurance companies changed their quoted rates after receiving the letter written by the physician on behalf of the individual.

Dr Shaheen concludes, “Despite the preponderance of data demonstrating a normal life expectancy associated with the condition, a diagnosis of Barrett's esophagus more than doubles life insurance premiums, and impacts the availability of health insurance.”

“Further steps to educate insurance companies about the risks associated with Barrett's esophagus are warranted, and patients should understand this additional "risk" of endoscopic screening for Barrett's esophagus.”

“There are significant indirect costs associated with a diagnosis of Barrett's esophagus.”

The American Journal of Gastroenterology 2005: 100(3): 577
09 March 2005

Go to top of page Email this page Email this page to a colleague

 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us